Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Humaniston Jan 30, 2021 12:45pm
243 Views
Post# 32428523

APHA PARTNER: AMP GERMAN CANABIS NOW = AMP ALTERNATIVE MED.

APHA PARTNER: AMP GERMAN CANABIS NOW = AMP ALTERNATIVE MED.IR-WORLD
01/29/2021 | 23:34
AMP German Cannabis Group changes company name to "AMP Alternative Medical Products"

ERFURT / BERLIN, Germany - January 29, 2021- AMP German Cannabis Group Inc. ("AMP" and or "the company") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that the company has announced that it has Company names in "AMP Alternative Medical Products Inc." has changed.

The Canadian Securities Exchange (the "CSE") will issue a bulletin announcing the effective date of the name change. The company's common stock is expected to be issued on or about Wednesday, February 3, 2021 under the new company name "AMP Alternative Medical Products Inc.", subject to the approval of the CSE. in thetrade start.

The company's stock symbol on the Canadian Stock exchangeCSE and the Frankfurt Stock Exchange will not change. AMP's new CUSIP number is 031896103 and the International Securities Identification Number (ISIN) is CA0318961038.

About AMP Alternative Medical Products
AMP Alternative Medical Products Inc. is licensed to import medical cannabis into Germany from Europe and other countries in accordance with the European Union's Good Manufacturing Practice ("EU-GMP"). AMP takes care of the procurement, storage, transport, delivery and sale of medical cannabis products directly to pharmaceutical distributors or pharmacists, the sole point of sale for medical cannabis to German patients with a doctor's prescription.

AMP sponsored a six-part series of discussions on medical cannabis in Germany. The Roundtable Series is available as a podcast or video. In episode no. 2, entitled Politics and Medical Cannabis in Germany, Dr. Wieland Schinnenburg, Member of the Bundestag (FDP), a current overview of the political aspects and challenges of the medical cannabis industry in Germany. The panelists also include Dr. Stefan Feuerstein, President of AMP, and Mr. Holger Scholze as moderator. Roundtable Series from AMP: www.amp-eu.de/roundtable
https://c.finative.eu/588f2a9f5289f/media/c/882/0/4/placeholder.png?ts=1612005972display
The easy way to build wealth. 3,000 euros start-up capital is enough.
This even works for "normal" people who have little or no experience with investing or the financial markets in general. The only requirement: EUR 3,000 start-up capital and a little patience. Then the dream of financial freedom can become a reality.
powered by finative
More information is available at: www.amp-eu.com
Contact:
Alex Blodgett, CEO & Director
Email: investor@amp-eu.com
AMP social media links:
- Twitter: https://twitter.com/AMP_Cannabis
- LinkedIn: www.linkedin.com/company/ampgermancannabisgroup
- Facebook: www.facebook.com/AMPGCG
- Instagram: www.instagram.com/ampgcg
- Podcast: https://ow.ly/EqBc50BJ4xw
Media collection: https://www.amp-eu.com/media-kit
The CSE and its regulatory bodies (referred to as the "Regulation Services Provider" in the CSE's Articles of Association) assume no responsibility for the adequacy or accuracy of this press release.
 


<< Previous
Bullboard Posts
Next >>